Invion

Subscribe to receive announcements and updates from Invion.

New investors

Home

Announcements

Updates

Lato

upload.jpg

We are excited to be profiled by Stockhead in The Australian with the publication showcasing our promising Photosoft technology in fighting cancers.

An excerpt of the article, which was written by respected business journalist Tim Boreham, is below:

Sunlight is meant to be the best disinfectant, but lesser known is the power of light and oxygen to kill cancer cells. Photodynamic  therapy (PDT) sounds like a new-age remedy, but in reality it is an  accepted cancer treatment that has spawned several approved drugs. 

PDT  was invented by Danish physiologist Prof Niels Finsen way back in 1903 –  and he even won a Nobel Prize for his efforts. In 1995, the US Food and  Drug Administration (FDA) approved a PDT drug for oesophageal cancer.

The only ASX-listed exponent of the art, Invion (ASX:IVX) hasn’t made any attention-grabbing announcements over the past few  years because it’s been doing the dull-but-important stuff such as  safety and toxicology studies.

Click here to read more https://www.theaustralian.com.au/business/stockhead/news/biocurious-invion-taps-the-power-of-light-to-zap-solid-tumours/news-story/e773afe8528f0e8fe69f48d5972df84a?btr=ceae0b927353eacfb02d927676673d5c

Invion Featured in The Australian/Stockhead